Valeant Buys Mexican Generic Drugmaker’s Assets

Valeant Pharmaceuticals said it will buy certain assets from Atlantis Pharma, a branded generic pharmaceutical company, for about $71 million, to expand its footprint in Mexico.
Calgary Herald